10th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Author Information
Author(s): J.H. Beijnen, Th.R. Boon, M.C. Christian, S.T. Crooke, J.A. Double, I.J. Fidler, J. Folkman, M. Friedman, G. Giaccone, A. Hanauske, A.L. Harris, F. Hausheer, W.K. Hong, S.B. Horwitz, R. Jain, S.B. Kaye, S.J. Korsmeyer, A. Matter, F. McCormick, C. Melief, J. Mendelsohn, H. Newell, H.M. Pinedo, S. Rosenberg, M. Sznol, J. Roth, N. Saijo, E.A. Sausville, T. Tursz, J. Verweij, D.D. Von Hoff, R.E. Wittes
Primary Institution: EORTC New Drug Development Office
Conclusion
The symposium aims to provide a global forum for discussing recent developments in anticancer drug research.
Supporting Evidence
- The symposium has been held every 2-3 years since 1978.
- Over 1,400 participants attended the last meeting in March 1996.
- The symposium covers both preclinical and clinical research.
- More workshops will be held due to positive feedback from previous events.
- Participants come from a diverse range of countries.
Takeaway
This is a big meeting where scientists talk about new medicines to help people with cancer.
Participant Demographics
Participants from over 35 countries, with a significant number from North America and the Far East.
Want to read the original?
Access the complete publication on the publisher's website